查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
神經刺激設備市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍：按產品、應用、最終用戶和地理位置
市場調查報告書
商品編碼
1372498

神經刺激設備市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍：按產品、應用、最終用戶和地理位置

Neurostimulation Devices Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product, Application, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 172 Pages | 訂單完成後即時交付

價格

神經刺激設備市場預計將從2022 年的58.02 億美元增至2030 年的118.25 億美元。預計2022 年至2030 年，該市場將以9.3% 的年複合成長率成長。神經系統疾病的患病率不斷上升，脊椎疾病病例不斷增加脊髓損傷是神經刺激設備市場發展的關鍵促進因素。然而，缺乏專業人士正在阻礙神經刺激設備市場的成長。

非侵入性治療需求不斷成長將推動未來神經刺激設備市場的發展

神經刺激是一個快速發展的領域，它利用神經系統的有針對性的電、機械、磁或熱刺激來改變放電神經元和內部神經元連接的特性，以治療各種神經系統疾病。非侵入性神經刺激裝置包括電驚厥治療（ECT）、經皮神經電刺激（TENS）、經顱電刺激（TES）、經顱直流電刺激（tDCS）、經顱交流電刺激（tACS）、靜磁刺激、隨機聲音刺激、週邊刺激等。神經刺激、超音波和聚焦超音波 (FUS)，包括腦神經刺激。非侵入性神經刺激技術是精神科領域最發達的技術。

患者和醫療保健提供者越來越喜歡非侵入性或微創治療方案，因為它們方便、無痛、安全且副作用最小。此外，它也廣泛應用於神經系統疾病。非侵入性治療旨在改善生活品質並減少言語、吞嚥和認知問題的影響。因此，對非侵入性治療的需求不斷成長將極大地推動未來神經刺激設備市場的成長。

政府正在對人們進行有關中風的教育，並提供改進的治療、醫療技術、增強的醫療保健覆蓋範圍和醫療保健環境。此外，國家也增加了非傳染性疾病防治的投入。此外，根據世界衛生組織的資料，中國約有95%的人口在農村和城市地區參保，政府針對低收入群體推出了兩項保險計劃：新型農村合作醫療制度（NRCMS）和城鎮居民保險。基本醫療保險（城鎮居民基本醫療保險）。這些計劃的啟動是因為健康費用是大多數人的重要支出之一。中國政府的這些措施將鼓勵人們接受手術以改善健康。由於日本和中國等國家醫療器材產業的不斷發展，神經刺激設備市場也有望成長。此外，神經病學的創新技術趨勢以及人工智慧（AI）和機器學習（ML）的快速採用是推動該地區市場的幾個因素。

此外，該國神經刺激設備市場的成長歸因於中風盛行率的上升和發病率的增加。神經外科需要先進的設備和高素質的醫療專業人員。德國擁有高素質的神經外科醫生；他們遵循最新的方案和手術程序。該國的神經病學中心擁有符合國際品質標準的最現代化的診斷和微創手術設備。

根據倫敦國王學院為歐洲中風聯盟所做的《歐洲中風負擔》報告中公佈的資料，德國每年記錄約88,922例中風病例，即每10萬居民中風51.7例。德國的中風盛行率約為 526,774 人，每 10 萬名居民中有 338.5 人中風。德國的中風死亡率也很高，每年有 75,861 人死於中風。根據《歐洲中風負擔》報告，預計2035年，中風病例將增加30%，到2035年底，中風盛行率將增加至19%。德國約有40萬人受到這種疾病的影響。2022年12月，由於人口老化，這數字還在增加。越來越多的人，包括年輕人，患有神經退化性疾病；在德國，超過 200 萬人患有失智症或帕金森氏症。根據德國阿茲海默症患者協會統計，2020年，阿茲海默症導致9,450人死亡，創歷史新高。阿茲海默症住院人數和死亡人數的增加很大程度上取決於德國人口老化。在德國，65 歲及以上人口增加了約 33%，到 2020 年達到 1,830 萬人。

因此，中風發病率顯著增加和人口老化導致神經系統疾病病例不斷增加，推動了德國神經刺激設備市場的成長。此外，政府的支持性措施和神經病學研究也促進了市場成長。因此，上述因素可能會促進 2022-2030 年神經刺激設備市場的成長。

神經刺激設備市場根據產品、應用、最終用戶和地理位置進行細分。根據產品，市場分為脊髓刺激器、深部腦部刺激器、薦神經刺激器、迷走神經刺激器等。脊髓刺激器細分市場在 2022 年佔據更大的市場佔有率，預計 2022 年至 2030 年期間年複合成長率將更高。神經刺激設備市場依應用分為疼痛管理、癲癇、尿失禁、大便失禁、帕金森氏症等。疼痛管理領域在 2022 年佔據了更大的市場佔有率，預計 2022 年至 2030 年期間年複合成長率將更高。依最終用戶分類，神經刺激設備市場分為醫院、專科診所等。醫院細分市場在 2022 年佔據最大市場佔有率，預計專科診所細分市場在 2022 年至 2030 年期間將實現最高的年複合成長率。專科診所是確保提供高標準臨床結果的卓越中心。這些中心致力於診斷、治療和管理神經系統疾病，並聘請訓練有素、具有專業技能的醫生、護理人員和護理人員。除了使用高階設備遵守預先定義的協議之外，更好的服務品質比其他設施更能為患者增加價值。這些診所簡化了服務並增強了便利的照護。

此外，專科診所在輕鬆、平靜的環境中提供醫學建議和監督的治療。除了提供多種診斷程序外，這些診所還幫助人們了解帕金森氏症、阿茲海默症、震顫和其他此類疾病患者的日常護理程序。這些患者可能會透過服用有間隙的藥物來接受運動症狀測試，以評估疾病的嚴重程度。成本效益和較短的等待時間等因素推動了該細分市場的成長。

這些疾病在全球範圍內的盛行率上升，導致越來越多的患者前往專科診所診斷和治療這些疾病，全球越來越多的專科診所提供更好的治療和專業服務。此外，市場成長歸因於全球專科診所滲透率的不斷成長。例如，2022年7月，俄亥俄州立大學韋克斯納醫學中心的神經病學團隊開設了一個新的專科診所，即帕金森氏症多學科診所。該診所充當帕金森氏症患者的“一站式商店”，讓他們獲得所需的所有護理，而無需在不同地點進行多次預約。在診所，患者可以與治療師、神經心理學家、經過專業培訓的運動神經學家和高級實踐提供者組成的團隊一起解決僵硬、記憶困難、不穩定/協調性差、震顫和疲勞等症狀。

美國食品藥物管理局 (FDA)、國家癌症研究所 (NCI)、衛生和預防部 (MoHAP) 和國家轉型計劃 (NTP) 是在準備神經刺激報告時參考的一些主要和次要來源設備市場。

目錄

第 1 章：簡介

  • Insight Partners 研究報告指南
  • 市場區隔

第 2 章：執行摘要

  • 重要見解
  • 神經刺激設備市場（依地理位置）

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：神經刺激設備市場格局

  • 概述
  • PEST分析
    • 全球PEST分析

第 5 章：神經刺激設備市場 - 主要產業動態

  • 市場促進因素
    • 神經系統疾病的盛行率不斷增加
    • 脊髓損傷病例不斷增加
  • 市場限制
    • 缺乏專業人才
  • 市場機會
    • 神經刺激設備的不斷進步和批准
  • 未來的趨勢
    • 對非侵入性治療的需求不斷成長
  • 影響分析

第 6 章：神經刺激設備市場 - 全球市場分析

  • 神經刺激設備市場收入，2022 - 2030

第 7 章：全球神經刺激設備市場 - 收入和 2030 年預測 - 按產品

  • 概述
  • 2022 年及 2030 年神經刺激設備市場收入佔有率，依產品分類 (%)
  • 脊髓刺激器
  • 深部腦部刺激器
  • 薦神經刺激器
  • 迷走神經刺激器
  • 其他

第 8 章：全球神經刺激設備市場 - 2030 年收入與預測 -按應用

  • 概述
  • 2022 年和 2030 年神經刺激設備市場收入佔有率，按應用分類 (%)
  • 疼痛管理
  • 癲癇
  • 尿失禁和大便失禁
  • 帕金森氏症
  • 其他

第 9 章：全球神經刺激設備市場 - 收入和 2030 年預測 - 按最終用戶

  • 概述
  • 2022 年和 2030 年神經刺激設備市場收入佔有率（按最終用戶分類）（%）
  • 醫院
  • 專科診所
  • 其他

第 10 章：神經刺激設備市場 - 2030 年收入與預測 - 地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第 11 章：神經刺激設備市場-產業格局

  • 概述
  • 有機發展
    • 概述
  • 無機發展
    • 概述

第 12 章：公司簡介

  • Medtronic Plc
  • Boston Scientific Corp
  • Abbott Laboratories
  • Nevro Corp
  • LivaNova Plc
  • Synapse Biomedical Inc.
  • Nalu Medical, Inc
  • ElectroCore Inc
  • MicroTransponder Inc.
  • Mainstay Medical

第 13 章：附錄

  • 關於我們
  • 專業術語
Product Code: TIPRE00002778

The neurostimulation devices market is projected to reach US$ 11.825 billion in 2030 from US$ 5.802 billion in 2022. The market is estimated to grow with a CAGR of 9.3% from 2022 to 2030. The growing prevalence of neurological diseases and increasing cases of spinal cord injury are the key driving factors behind the neurostimulation devices market development. However, lack of expert professionals is hampering the neurostimulation devices market growth.

Rising Demand for Noninvasive Treatment to Boost the Neurostimulation Devices Market in Future

Neurostimulation is a rapidly evolving field that uses targeted electrical, mechanical, magnetic, or thermal stimulation of the nervous system to alter the properties of firing neuronal and internal neuronal connectivity to treat various neurological disorders. Noninvasive neurostimulation devices include electroconvulsive therapy (ECT), transcutaneous electrical nerve stimulation (TENS), transcranial electrical stimulation (TES), transcranial direct current stimulation (tDCS), transcranial alternating current stimulation (tACS), static magnetic stimulation, random sound stimulation, peripheral nerve stimulation, ultrasound, and focused ultrasound (FUS), including cranial nerve stimulation. Noninvasive neurostimulation techniques are the most developed in psychiatry.

Patients and healthcare providers increasingly prefer noninvasive or minimally invasive treatment options as they are convenient, painless, safe, and have minimal side effects. In addition, it is widely used in neurological diseases. Noninvasive treatments aim to improve the quality of life and reduce the impact of speech, swallowing, and cognitive problems. Therefore, growing demand for noninvasive treatments would significantly fuel the neurostimulation devices market growth in the future.

The government is educating people about stroke and offering improved treatment, medical technology, and enhanced healthcare coverage and healthcare environment. Also, the country has invested more in preventing and treating noncommunicable diseases. Additionally, as per the data of WHO, ~95% of the population of China is insured in rural and urban areas, as the government introduced two insurance programs for low-income groups: the New Rural Cooperative Medical System (NRCMS) and Urban Resident Basic Medical Insurance (URBMI). The programs were launched as the cost of health is one of the significant expenses for most of the population. These initiatives by the Chinese government would encourage the population to undergo surgeries to improve health. The neurostimulation devices market is also expected to grow due to the rising development of the medical device industry in countries such as Japan and China. In addition, innovative technology trends in neurology and the rapid adoption of artificial intelligence (AI) and machine learning (ML) are a few factors that drive the market in the region.

Furthermore, the neurostimulation devices market growth in the country is attributed to the rising prevalence of stroke and increasing incidence. Neurosurgery requires advanced equipment and highly qualified medical professionals. Germany has highly qualified neurosurgeons; they follow the latest protocols and surgical procedures. Neurology centers in the country have the most modern diagnostic and minimally invasive surgical devices that meet international quality standards.

According to the data published in the Burden of Stroke in Europe report conducted by King's College London for the Stroke Alliance for Europe, Germany records around 88,922 stroke cases annually, which is 51.7 strokes per 100,000 inhabitants. The prevalence of stroke in Germany was ~ 526,774 that accounts for 338.5 strokes per 100,000 residents. Germany also has a significant mortality rate of stroke, i.e., 75,861 deaths due to stroke per year. According to the Burden of Stroke in Europe report, it is expected that stroke cases will increase by 30% by 2035, and the prevalence of stroke will grow to 19% by the end of 2035.approximately 400,000 people were affected with the disease in Germany in December 2022, and the numbers are increasing due to demographic aging. More and more people, including younger people, suffer from neurodegenerative diseases; in Germany, more than 2 million people have dementia or Parkinson's. According to the German Association for Alzheimer's Patients, in 2020, 9,450 deaths were caused due to Alzheimer's, recording the highest figure. The increase in hospitalizations and deaths with Alzheimer's diagnosis is highly dependent on the aging population in Germany. In Germany, people aged 65 and above had increased by ~33% and reached 18.3 million in 2020.

Thus, significantly growing incidence of stroke and rising aging population resulting in growing cases of neurological disorders drive the neurostimulation devices market growth in Germany. Furthermore, supportive government initiatives and research in neurology also boost market growth. Therefore, the factors mentioned above are likely to contribute to the neurostimulation devices market growth during 2022-2030.

The neurostimulation devices market is segmented on the basis of product, application, end user, and geography. Based on product, the market is segmented into spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator, and others. The spinal cord stimulator segment held a larger market share in 2022 and the same is anticipated to register a higher CAGR during 2022-2030. The neurostimulation devices market, by application, is segmented into pain management, epilepsy, urinary and fecal incontinence, Parkinson's disease, and others. The pain management segment held a larger market share in 2022 and the same is anticipated to register a higher CAGR during 2022-2030. The neurostimulation devices market, by end user, is bifurcated into hospitals, specialty clinics, and others. The hospitals segment held the largest share of the market in 2022 and specialty clinics segment is anticipated to register the highest CAGR in the market during 2022-2030. Specialty clinics are centers of excellence assured to deliver high standards of clinical outcomes. These centers are dedicated to diagnosing, treating, and managing neurological disorders and employ highly trained doctors, paramedics, and nursing personnel with specialized skills. Besides adhering to predefined protocols using high-end equipment, better service quality adds value to patients more than other facilities. These clinics streamline services and enhance convenient care.

In addition, specialty clinics provide medically recommended and supervised treatments in a relaxing and calming environment. These clinics also help to educate people regarding daily care routines for patients who have Parkinson's disease and Alzheimer's disease, tremors, and other such conditions, apart from providing several diagnostic procedures. These patients might undergo testing of motor symptoms by taking medications with gaps to assess the disease severity. Factors such as cost-effectiveness and shorter waiting times fuel the segment growth.

A global rise in the prevalence of these conditions has led to a growing number of patients visiting specialty clinics to diagnose and treat these conditions, with an increasing number of specialty clinics on the global level that offer better treatment and specialized services. In addition, the market growth is attributable to the growing penetration rate of specialty clinics across the globe. For instance, in July 2022, the neurology teams of Ohio State University Wexner Medical Center opened a new specialty clinic, the Parkinson's Disease Multidisciplinary Clinic. The clinic acts as a "one-stop shop" for Parkinson's disease patients to receive all the care they need without taking multiple appointments in different locations. At the clinic, patients can address symptoms such as stiffness, memory difficulties, unsteadiness/poor coordination, tremors, and fatigue with a team that includes therapists, neuropsychologists, subspecialty-trained movement neurologists, and advanced practice providers.

The Food and Drug Administration (FDA), National Cancer Institute (NCI), Ministry of Health and Prevention (MoHAP), and National Transformation Program (NTP) are among some of the primary and secondary sources referred to while preparing the report on the neurostimulation devices market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the neurostimulation devices market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the neurostimulation devices market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the neurostimulation devices market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Neurostimulation Devices Market, by Geography (US$ Million)

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Neurostimulation Devices Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Global PEST Analysis

5. Neurostimulation Devices Market - Key Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Prevalence of Neurological Disorders
    • 5.1.2 Rising Cases of Spinal Cord Injury
  • 5.2 Market Restraints
    • 5.2.1 Lack of Expert Professionals
  • 5.3 Market Opportunities
    • 5.3.1 Growing Advances and Approvals for Neurostimulation Devices
  • 5.4 Future Trends
    • 5.4.1 Rising Demand for Noninvasive Treatment
  • 5.5 Impact Analysis

6. Neurostimulation Devices Market - Global Market Analysis

  • 6.1 Neurostimulation Devices Market Revenue (US$ Mn), 2022 - 2030

7. Global Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Product

  • 7.1 Overview
  • 7.2 Neurostimulation Devices Market Revenue Share, by Product 2022 & 2030 (%)
  • 7.3 Spinal Cord Stimulator
    • 7.3.1 Overview
    • 7.3.2 Spinal Cord Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Deep Brain Stimulator
    • 7.4.1 Overview
    • 7.4.2 Deep Brain Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Sacral Nerve Stimulator
    • 7.5.1 Overview
    • 7.5.2 Sacral Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Vagus Nerve Stimulator
    • 7.6.1 Overview
    • 7.6.2 Vagus Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Others
    • 7.7.1 Overview
    • 7.7.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

8. Global Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Application

  • 8.1 Overview
  • 8.2 Neurostimulation Devices Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Pain Management
    • 8.3.1 Overview
    • 8.3.2 Pain Management: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Epilepsy
    • 8.4.1 Overview
    • 8.4.2 Epilepsy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Urinary and Fecal Incontinence
    • 8.5.1 Overview
    • 8.5.2 Urinary and Fecal Incontinence: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Parkinson's Disease
    • 8.6.1 Overview
    • 8.6.2 Parkinson's Disease: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Others
    • 8.7.1 Overview
    • 8.7.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9. Global Neurostimulation Devices Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 Neurostimulation Devices Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Specialty Clinics
    • 9.4.1 Overview
    • 9.4.2 Specialty Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Others
    • 9.5.1 Overview
    • 9.5.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

10. Neurostimulation Devices Market - Revenue and Forecast to 2030 - Geographic Analysis

  • 10.1 North America: Neurostimulation Devices Market
    • 10.1.1 Overview
    • 10.1.2 North America: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.2.1 North America: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
      • 10.1.2.2 North America: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
      • 10.1.2.3 North America: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
    • 10.1.3 North America: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
      • 10.1.3.1 US: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.3.2 US: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.3.2.1 US: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.1.3.2.2 US: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
        • 10.1.3.2.3 US: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
      • 10.1.3.3 Canada: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.3.4 Canada: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.3.4.1 Canada: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.1.3.4.2 Canada: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
        • 10.1.3.4.3 Canada: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
      • 10.1.3.5 Mexico: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.3.6 Mexico: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.3.6.1 Mexico: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.1.3.6.2 Mexico: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
        • 10.1.3.6.3 Mexico: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  • 10.2 Europe: Neurostimulation Devices Market
    • 10.2.1 Overview
    • 10.2.2 Europe: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.2.2.1 Europe: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
      • 10.2.2.2 Europe: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
      • 10.2.2.3 Europe: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
    • 10.2.3 Europe: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
      • 10.2.3.1 Germany: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 10.2.3.2 Germany: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.3.2.1 Germany: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.2.3.2.2 Germany: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
        • 10.2.3.2.3 Germany: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
      • 10.2.3.3 UK: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 10.2.3.4 UK: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.3.4.1 UK: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.2.3.4.2 UK: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
        • 10.2.3.4.3 UK: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
      • 10.2.3.5 France: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 10.2.3.6 France: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.3.6.1 France: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.2.3.6.2 France: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
        • 10.2.3.6.3 France: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
      • 10.2.3.7 Italy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 10.2.3.8 Italy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.3.8.1 Italy: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.2.3.8.2 Italy: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
        • 10.2.3.8.3 Italy: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
      • 10.2.3.9 Spain: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 10.2.3.10 Spain: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.3.10.1 Spain: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.2.3.10.2 Spain: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
        • 10.2.3.10.3 Spain: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
      • 10.2.3.11 Rest of Europe: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 10.2.3.12 Rest of Europe: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.3.12.1 Rest of Europe: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.2.3.12.2 Rest of Europe: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
        • 10.2.3.12.3 Rest of Europe: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  • 10.3 Asia Pacific: Neurostimulation Devices Market
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.3.2.1 Asia Pacific: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
      • 10.3.2.2 Asia Pacific: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
      • 10.3.2.3 Asia Pacific: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
    • 10.3.3 Asia Pacific: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
      • 10.3.3.1 China: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 10.3.3.2 China: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.3.2.1 China: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.3.3.2.2 China: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
        • 10.3.3.2.3 China: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
      • 10.3.3.3 Japan: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 10.3.3.4 Japan: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.3.4.1 Japan: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.3.3.4.2 Japan: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
        • 10.3.3.4.3 Japan: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
      • 10.3.3.5 India: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 10.3.3.6 India: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.3.6.1 India: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.3.3.6.2 India: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
        • 10.3.3.6.3 India: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
      • 10.3.3.7 Australia: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 10.3.3.8 Australia: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.3.8.1 Australia: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.3.3.8.2 Australia: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
        • 10.3.3.8.3 Australia: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
      • 10.3.3.9 South Korea: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 10.3.3.10 South Korea: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.3.10.1 South Korea: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.3.3.10.2 South Korea: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
        • 10.3.3.10.3 South Korea: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
      • 10.3.3.11 Rest of Asia Pacific: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 10.3.3.12 Rest of Asia Pacific: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.3.12.1 Rest of Asia Pacific: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.3.3.12.2 Rest of Asia Pacific: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
        • 10.3.3.12.3 Rest of Asia Pacific: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  • 10.4 Middle East & Africa Neurostimulation Devices Market
    • 10.4.1 Overview
    • 10.4.2 Middle East & Africa: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.4.2.1 Middle East & Africa: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
      • 10.4.2.2 Middle East & Africa: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
      • 10.4.2.3 Middle East & Africa: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
    • 10.4.3 Middle East & Africa: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
      • 10.4.3.1 Saudi Arabia: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 10.4.3.2 Saudi Arabia: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.3.2.1 Saudi Arabia: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.4.3.2.2 Saudi Arabia: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
        • 10.4.3.2.3 Saudi Arabia: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
      • 10.4.3.3 South Africa: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 10.4.3.4 South Africa: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.3.4.1 South Africa: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.4.3.4.2 South Africa: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
        • 10.4.3.4.3 South Africa: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
      • 10.4.3.5 UAE: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 10.4.3.6 UAE: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.3.6.1 UAE: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.4.3.6.2 UAE: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
        • 10.4.3.6.3 UAE: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
      • 10.4.3.7 Rest of Middle East & Africa: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 10.4.3.8 Rest of Middle East & Africa: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.3.8.1 Rest of Middle East & Africa: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.4.3.8.2 Rest of Middle East & Africa: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
        • 10.4.3.8.3 Rest of Middle East & Africa: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  • 10.5 South & Central America: Neurostimulation Devices Market
    • 10.5.1 Overview
    • 10.5.2 South & Central America: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.5.2.1 South & Central America: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
      • 10.5.2.2 South & Central America: Neurostimulation Devices Market, By Application, 2020-2030 (US$ Million)
      • 10.5.2.3 South & Central America: Neurostimulation Devices Market, By End User, 2020-2030 (US$ Million)
    • 10.5.3 South & Central America: Neurostimulation Devices Market Share by Country - 2022 & 2030, (%)
      • 10.5.3.1 Brazil: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 10.5.3.2 Brazil: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.5.3.2.1 Brazil: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.5.3.2.2 Brazil: Neurostimulation Devices Market, By Application, 2020-2030 (US$ Million)
        • 10.5.3.2.3 Brazil: Neurostimulation Devices Market, By End User, 2020-2030 (US$ Million)
      • 10.5.3.3 Argentina: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 10.5.3.4 Argentina: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.5.3.4.1 Argentina: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.5.3.4.2 Argentina: Neurostimulation Devices Market, By Application, 2020-2030 (US$ Million)
        • 10.5.3.4.3 Argentina: Neurostimulation Devices Market, By End User, 2020-2030 (US$ Million)
      • 10.5.3.5 Rest of South & Central America: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 10.5.3.6 Rest of South & Central America: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.5.3.6.1 Rest of South & Central America: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.5.3.6.2 Rest of South & Central America: Neurostimulation Devices Market, By Application, 2020-2030 (US$ Million)
        • 10.5.3.6.3 Rest of South & Central America: Neurostimulation Devices Market, By End User, 2020-2030 (US$ Million)

11. Neurostimulation Devices Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Organic Developments
    • 11.2.1 Overview
  • 11.3 Inorganic Developments
    • 11.3.1 Overview

12. Company Profiles

  • 12.1 Medtronic Plc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Boston Scientific Corp
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Abbott Laboratories
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Nevro Corp
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 LivaNova Plc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Synapse Biomedical Inc.
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Nalu Medical, Inc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 ElectroCore Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 MicroTransponder Inc.
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Mainstay Medical
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Neurostimulation Devices Market Segmentation
  • Table 2. North America Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. North America Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. North America Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. US Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. US Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. US Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. Canada Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Canada Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Canada Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Mexico Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Mexico Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Mexico Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Europe Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Europe Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Europe Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Germany Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Germany Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Germany Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. UK Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. UK Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. UK Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. France Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. France Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. France Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 26. Italy Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 27. Italy Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 28. Italy Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 29. Spain Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 30. Spain Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 31. Spain Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 32. Rest of Europe Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 33. Rest of Europe Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 34. Rest of Europe Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 35. Asia Pacific Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 36. Asia Pacific Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 37. Asia Pacific Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 38. China Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 39. China Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 40. China Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 41. Japan Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 42. Japan Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 43. Japan Neurostimulation Devices Market, by End User- Revenue and Forecast to 2030 (US$ Million)
  • Table 44. India Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 45. India Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 46. India Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 47. Australia Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 48. Australia Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 49. Australia Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 50. South Korea Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 51. South Korea Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 52. South Korea Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 53. Rest of Asia Pacific Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 54. Rest of Asia Pacific Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 55. Rest of Asia Pacific Neurostimulation Devices Market, by End User- Revenue and Forecast to 2030 (US$ Million)
  • Table 56. Middle East & Africa Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 57. Middle East & Africa Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 58. Middle East & Africa Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 59. Saudi Arabia Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 60. Saudi Arabia Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 61. Saudi Arabia Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 62. South Africa Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 63. South Africa Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 64. South Africa Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 65. UAE Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 66. UAE Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 67. UAE Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 68. Rest of Middle East & Africa Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 69. Rest of Middle East & Africa Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 70. Rest of Middle East & Africa Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 71. South & Central America Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 72. South & Central America: Neurostimulation Devices Market, By Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 73. South & Central America: Neurostimulation Devices Market, By End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 74. Brazil Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 75. Brazil: Neurostimulation Devices Market, By Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 76. Brazil: Neurostimulation Devices Market, By End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 77. Argentina Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 78. Argentina: Neurostimulation Devices Market, By Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 79. Argentina: Neurostimulation Devices Market, By End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 80. Rest of South & Central Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 81. Rest of South & Central America: Neurostimulation Devices Market, By Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 82. Rest of South & Central America: Neurostimulation Devices Market, By End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 83. Organic Developments Done by Companies
  • Table 84. Inorganic Developments Done by Companies
  • Table 85. Glossary of Terms, Neurostimulation Devices Market

List Of Figures

  • Figure 1. Neurostimulation Devices Market Segmentation, By Geography
  • Figure 2. Global - PEST Analysis
  • Figure 3. Neurostimulation Devices Market: Key Industry Dynamics
  • Figure 4. Neurostimulation Devices Market: Impact Analysis of Drivers and Restraints
  • Figure 5. Neurostimulation Devices Market Revenue (US$ Mn), 2020 - 2030
  • Figure 6. Global Neurostimulation Devices Market, By Geography Forecast Analysis, 2022 & 2030
  • Figure 7. Neurostimulation Devices Market Revenue Share, by Product 2022 & 2030 (%)
  • Figure 8. Spinal Cord Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Deep Brain Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Sacral Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Vagus Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Neurostimulation Devices Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 14. Pain Management: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Epilepsy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Urinary and Fecal Incontinence: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Parkinson's Disease: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Neurostimulation Devices Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 20. Hospitals & Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Specialty Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. North America: Neurostimulation Devices Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 24. North America Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. North America: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
  • Figure 26. US: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Canada: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Mexico: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Europe: Neurostimulation Devices Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 30. Europe Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. Europe: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
  • Figure 32. Germany: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 33. UK: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 34. France: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 35. Italy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 36. Spain: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 37. Rest of Europe: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 38. Asia Pacific: Neurostimulation Devices Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 39. Asia Pacific Neurostimulation Devices Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 40. Asia Pacific: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
  • Figure 41. China: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 42. Japan: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 43. India: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 44. Australia: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 45. South Korea: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 46. Rest of Asia Pacific: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 47. Middle East & Africa: Neurostimulation Devices Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 48. Middle East & Africa Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 49. Middle East & Africa: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
  • Figure 50. Saudi Arabia: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 51. South Africa: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 52. UAE: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 53. Rest of Middle East & Africa: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 54. South & Central America: Neurostimulation Devices Market, By Key Country - Revenue (2022) (US$ Million)
  • Figure 55. South & Central America: Neurostimulation Devices Market- Revenue and Forecasts to 2030 (US$ Million)
  • Figure 56. South & Central America: Neurostimulation Devices Market Share by Country - 2022 & 2030, (%)
  • Figure 57. Brazil: Neurostimulation Devices Market- Revenue and Forecasts to 2030 (US$ Million)
  • Figure 58. Argentina: Neurostimulation Devices Market- Revenue and Forecasts to 2030 (US$ Million)
  • Figure 59. Rest of South & Central America: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)